A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Name: A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas
Published: 2026
License: Public Domain

Kure Cells, INC · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

lymphoma nonhodgkin, marginal zone b cell lymphoma, diffuse large b cell lymphoma (dlbcl), follicular b-cell non-hodgkin's lymphoma, car t cell therapy, car t-cell, non-hodgkin lymphoma, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Related documents